Literature DB >> 10857509

Driving skills in elderly persons with stroke: comparison of two new assessment options.

P Klavora1, R J Heslegrave, M Young.   

Abstract

OBJECTIVE: To compare the effectiveness of two methods of assessing off-road driving skills that claim to predict on-road driving fitness of persons with stroke.
METHOD: Fifty-six persons with stroke (age 44 to 82 yrs; mean, 60.2 yrs) completed the 2 off-road driving assessments along with standard clinical and on-road driving tests. MAIN OUTCOME MEASURES: Linear stepwise regression on 4 variables of the Dynavision Performance Assessment Battery (DPAB), the Cognitive Behavioral Driver's Inventory (CBDI) variable (composite score), and the variables of age, gender, and lesion side.
RESULTS: A 4-minute endurance subtest from the DPAB was superior to the CBDI in predicting success/failure in the on-road driving test (75%). However, success on both the 4-minute endurance subtest from the DPAB and the CBDI tests significantly improved the prediction of on-road success. If participants passed the CBDI and the endurance test from the DPAB, they also passed the on-road assessment.
CONCLUSION: Driving fitness of elderly persons with stroke can be assessed with reasonable accuracy using off-road tests, minimizing the expense and risk associated with on-road assessments in this population.

Entities:  

Mesh:

Year:  2000        PMID: 10857509     DOI: 10.1016/s0003-9993(00)90096-0

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  2 in total

1.  Dynavision Normative Data for Healthy Adults: Reaction Test Program.

Authors:  Cherie Blackwell; Kathy Cary; Kami Holst; Kristen Mandle; Lori Dryg; Susan Clemens; Jon H Lemke; Sarah Castro; Emma Hendricks; Ryan Kelly
Journal:  Am J Occup Ther       Date:  2020 Jan/Feb

2.  Reliability of the Dynavision task in virtual reality to explore visuomotor phenotypes.

Authors:  Yvan Pratviel; Veronique Deschodt-Arsac; Florian Larrue; Laurent M Arsac
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.